ProPhase Labs Inc (NASDAQ: PRPH) kicked off on Tuesday, down -0.81% from the previous trading day, before settling in for the closing price of $0.39. Over the past 52 weeks, PRPH has traded in a range of $0.22-$7.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 120.73% over the last five years. While this was happening, its average annual earnings per share was recorded -29.59%. With a float of $26.37 million, this company’s outstanding shares have now reached $29.87 million.
The firm has a total of 113 workers. Let’s measure their productivity. In terms of profitability, gross margin is -32.38%, operating margin of -277.69%, and the pretax margin is -298.21%.
ProPhase Labs Inc (PRPH) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of ProPhase Labs Inc is 11.73%, while institutional ownership is 8.10%.
ProPhase Labs Inc (PRPH) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -29.59% per share during the next fiscal year.
ProPhase Labs Inc (NASDAQ: PRPH) Trading Performance Indicators
Take a look at ProPhase Labs Inc’s (PRPH) current performance indicators. Last quarter, stock had a quick ratio of 1.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of ProPhase Labs Inc (PRPH)
Analysing the last 5-days average volume posted by the [ProPhase Labs Inc, PRPH], we can find that recorded value of 0.91 million was lower than the volume posted last year of 11.27 million. As of the previous 9 days, the stock’s Stochastic %D was 45.79%. Additionally, its Average True Range was 0.08.
During the past 100 days, ProPhase Labs Inc’s (PRPH) raw stochastic average was set at 7.76%, which indicates a significant decrease from 37.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 122.31% in the past 14 days, which was lower than the 177.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4573, while its 200-day Moving Average is $1.9511. Now, the first resistance to watch is $0.4157. This is followed by the second major resistance level at $0.4403. The third major resistance level sits at $0.4657. If the price goes on to break the first support level at $0.3657, it is likely to go to the next support level at $0.3403. Should the price break the second support level, the third support level stands at $0.3157.
ProPhase Labs Inc (NASDAQ: PRPH) Key Stats
The company with the Market Capitalisation of 11.68 million has total of 23,874K Shares Outstanding. Its annual sales at the moment are 44,380 K in contrast with the sum of -16,780 K annual income. Company’s last quarter sales were recorded 3,150 K and last quarter income was -6,590 K.
